The emerging approach of this peptide represents a exciting development in the care of type 2 diabetes. Different to existing medications, tirzepatide targets two pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – providing enhanced blood sugar regulation and potential weig